Impact of first-line fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with advanced gastroesophageal adenocarcinoma: A retrospective analysis.

Authors

Aline Lino

Aline Da Rocha Lino

Centro Oncologico Antônio Ermírio de Moraes, São Paulo, Brazil

Aline Da Rocha Lino , Raphael Brandao Moreira , Jessica Ribeiro Gomes , Tarcia Tarciane Soares de Sousa , Carina Mina Abrahao , Rodnei Merlrina Martins Junior , Matheus Bongers Alessandretti , Marcus Paulo Fernandes Amarante , Fabio Augusto Barros Schutz , Carolina Kawamura , Rafael Schmerling , Marcelo Rocha Cruz , Fernando C. Maluf , Antonio C. Buzaid , Renata D'Alpino Peixoto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 216)

DOI

10.1200/jco.2015.33.3_suppl.216

Abstract #

216

Poster Bd #

E12

Abstract Disclosures

Similar Posters